Irbesartan Tablet
Product Images NDC 62332-041

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 62332-041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 And 2 (Irbesartan Fig1 2)

FDA Label Image

Figure 3 (Irbesartan Fig3)

Figure 3 (Irbesartan Fig3)
This is a report of a clinical trial involving Irbesartan, Amlodipine and Placebo over a period of time spanning from 0 to 60 months. The trial measured the effectiveness of Irbesartan compared to Amlodipine and Placebo in reducing Cumulative Event Rate (%). The report provides values for RR (Relative Risk), p (p-value) and the Cumulative Event Rate for the different drugs over time. There is no readable information in the line "cwsn HRENEABHEBRII".*
FDA Label Image

Irbesartan mg150

FDA Label Image

Irbesartan mg300

Irbesartan mg300
This is a description of a medication with the NDC code of 62332-043-30. The tablets contain 300 mg oesarans USP and are from the manufacturer, Aembic Pharmaceuticals Limited. The medicine comes in a bottle of 30 tablets and should be stored at a controlled room temperature of 15-30°C (59-36°F). The GTIN is 00362332043309, and the product's expiration date and lot number are shown in the coding area.*
FDA Label Image

Irbesartan mg75

Irbesartan mg75
This is a description of a medication called IDESArtan 8. Each tablet contains 5mg of a substance called USP. The medicine is manufactured by Alembic Pharmaceuticals and comes in a bottle of 30 tablets. The instructions recommend storing it at a temperature below 25C (77F) and away from sunlight. It is important to note that it is a prescription medication and should be used only under a doctor's supervision.*
FDA Label Image

Structure (Irbesartan Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.